NAMPT and peripheral neuropathy: In line with the notion that skewed NMN/NAD+ can cause peripheral neuropathy, NAMPT inhibition using the novel agent A4276 was found to protect against Wallerian degeneration (during which NMNAT2 is downregulated) and peripheral neuropathy induced by vincristine and paclitaxel [74].